News
03-11-2016, 04:30 AM
Approximately a quarter of women with HER2 positive breast cancer, who were treated with a combination of the targeted drugs lapatinib and trastuzumab before surgery and chemotherapy, saw their tumours shrink significantly or even disappear, according to results from a clinical trial.
More... (http://www.news-medical.net/news/20160311/New-drug-combination-treatment-makes-breast-cancer-tumours-disappear-in-just-11-days.aspx)
More... (http://www.news-medical.net/news/20160311/New-drug-combination-treatment-makes-breast-cancer-tumours-disappear-in-just-11-days.aspx)